Biotelemetry Inc. (BEAT) 15.89 $BEAT
42.6% Return Seen to Date on SmarTrend CardioNet Call (BEAT)
Comtex SmarTrend(R) - Wed Jun 15, 12:18AM CDT
SmarTrend identified an Uptrend for CardioNet (NASDAQ:BEAT) on February 18th, 2016 at $11.21. In approximately 4 months, CardioNet has returned 42.64% as of today's recent price of $15.99.
BEAT: 15.89 (-0.13)
HealthEquity Q1 Earnings Top, Revenues Rise Y/Y; View Up
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 7:35AM CDT
Shares of HealthEquity Inc (HQY) increased almost 4% in after-hours following impressive first-quarter fiscal 2017 results.
AIRM: 36.93 (+0.90), HQY: 29.18 (+0.52), BEAT: 15.89 (-0.13), AHS: 40.31 (+0.83)
The Zacks Analyst Blog Highlights: Entercom Communications, BioTelemetry, First Majestic Silver, BG Staffing and Orrstown Financial Services
Zacks Equity Research - Zacks Investment Research - Tue May 31, 8:30AM CDT
The Zacks Analyst Blog Highlights: Entercom Communications, BioTelemetry, First Majestic Silver, BG Staffing and Orrstown Financial Services
ETM: 13.85 (+0.25), AG: 12.40 (-0.06), BEAT: 15.89 (-0.13), BGSF: 16.14 (+0.42), ORRF: 18.28 (+0.46)
Shares of BEAT Up 52.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue May 31, 12:15AM CDT
SmarTrend identified an Uptrend for CardioNet (NASDAQ:BEAT) on February 18th, 2016 at $11.21. In approximately 3 months, CardioNet has returned 52.19% as of today's recent price of $17.06.
BEAT: 15.89 (-0.13)
5 Breakout Stocks Under $20
Zacks Equity Research - Zacks Investment Research - Fri May 27, 11:15AM CDT
The breakout strategy is probably the most commonly used one by active investors.
ETM: 13.85 (+0.25), AG: 12.40 (-0.06), BEAT: 15.89 (-0.13), BGSF: 16.14 (+0.42), ORRF: 18.28 (+0.46)
Medical Service Stocks Should be on your Buying Radar
Zacks Premium Research - Zacks Investment Research - Wed May 25, 3:47PM CDT
Investing in this industry now could pay off for you over the short term.
HQY: 29.18 (+0.52), BEAT: 15.89 (-0.13), AHS: 40.31 (+0.83)
Uptrend Call Working As CardioNet Stock Rises 36.5% (BEAT)
Comtex SmarTrend(R) - Mon May 23, 12:56PM CDT
SmarTrend identified an Uptrend for CardioNet (NASDAQ:BEAT) on February 18th, 2016 at $11.21. In approximately 3 months, CardioNet has returned 36.53% as of today's recent price of $15.31.
BEAT: 15.89 (-0.13)
Waters Corp. Expands Xevo Line with Xevo TQ-XS Launch
Zacks Equity Research - Zacks Investment Research - Tue May 17, 8:44AM CDT
Waters Corporation (WAT) expanded its portfolio of Xevo mass spectrometers with the launch of Xevo TQ-XS mass spectrometer, which is arguably the most sensitive instrument of its kind in the market.
BEAT: 15.89 (-0.13), BRKR: 24.40 (+0.14), PKI: 54.23 (+0.99), WAT: 138.40 (+1.17)
BioTelemetry, Inc. Announces the Completion of Its Acquisition of VirtualScopics, Inc.
GlobeNewswire - Wed May 11, 8:25AM CDT
BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that it has completed its acquisition of VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions. The acquisition comes after the successful completion of the all cash tender offer for all outstanding common and preferred shares of VirtualScopics. The total purchase consideration was approximately $15.0 million, net of cash and debt acquired.
VSCP: 4.04 (+0.01), BEAT: 15.89 (-0.13)
BioTelemetry, Inc. Announces Results of Tender Offer for Shares of VirtualScopics, Inc.
GlobeNewswire - Tue May 10, 7:05AM CDT
BioTelemetry, Inc. (NASDAQ: BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that the tender offer of its wholly owned subsidiary, BioTelemetry Research Acquisition Corporation ("Offeror"
, to purchase all outstanding common and preferred shares of VirtualScopics, Inc. ("VirtualScopics"; (NASDAQ:VSCP) at an offer price of $4.05 per share for VirtualScopics' common stock, $336.30 per share for VirtualScopics' Series A and Series B Convertible Preferred Stock and $920.00 per share for VirtualScopics' Series C-1 Convertible Preferred Stock, expired as scheduled at 5:00 p.m., New York City time, on Monday, May 9, 2016, and was not extended.
VSCP: 4.04 (+0.01), BEAT: 15.89 (-0.13)
BioTelemetry, Inc. Appoints Colin Hill to Its Board of Directors
GlobeNewswire - Fri May 06, 3:05PM CDT
BioTelemetry, Inc. (NASDAQ:BEAT) the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today the appointment of Colin Hill to its Board of Directors.
BEAT: 15.89 (-0.13)
Can The Uptrend Continue for BioTelemetry (BEAT)?
Zacks Equity Research - Zacks Investment Research - Fri May 06, 8:03AM CDT
Investors certainly have to be happy with BioTelemetry, Inc. (BEAT) and its short term performance.
BEAT: 15.89 (-0.13)
Why BioTelemetry (BEAT) Stock Might be a Great Pick
Zacks Equity Research - Zacks Investment Research - Wed May 04, 7:39AM CDT
BioTelemetry (BEAT) is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
BEAT: 15.89 (-0.13)
Looking for a Top Momentum Stock? 3 Reasons Why BioTelemetry (BEAT) is a Great Choice
Zacks Equity Research - Zacks Investment Research - Tue May 03, 8:16AM CDT
BioTelemetry is a great momentum stock and has been witnessing positive activity in the earnings estimate revision front as well
BEAT: 15.89 (-0.13)
Acadia Healthcare (ACHC) Beats on Q1 Earnings; Stock Up
Zacks Equity Research - Zacks Investment Research - Mon May 02, 9:44AM CDT
Shares of Acadia Healthcare Company Inc (ACHC) increased 1.6% to close at $63.19 on Apr 29, after the company reiterated its full-year 2016 guidance.
ACHC: 62.44 (+1.65), BAX: 45.96 (+1.02), BEAT: 15.89 (-0.13), EW: 99.08 (+1.04)
The Zacks Analyst Blog Highlights: Daqo New Energy, BioTelemetry, Ebix, Primo Water and Nanometrics
Zacks Equity Research - Zacks Investment Research - Mon May 02, 8:30AM CDT
The Zacks Analyst Blog Highlights: Daqo New Energy, BioTelemetry, Ebix, Primo Water and Nanometrics
PRMW: 10.89 (+0.16), DQ: 21.10 (+0.95), BEAT: 15.89 (-0.13), EBIX: 48.61 (+0.90), NANO: 20.62 (+0.26)
Universal Health (UHS) Tops Q1 Earnings on Strong Sales
Zacks Equity Research - Zacks Investment Research - Mon May 02, 5:53AM CDT
Universal Health Services Inc. (UHS) reported first-quarter 2016 adjusted earnings of $1.98 per share, which beat the Zacks Consensus Estimate by 12 cents.
BAX: 45.96 (+1.02), UHS: 138.28 (+3.44), BEAT: 15.89 (-0.13), EW: 99.08 (+1.04)
42.6% Return Seen to Date on SmarTrend CardioNet Call (BEAT)
Comtex SmarTrend(R) - Wed Jun 15, 12:18AM CDT
SmarTrend identified an Uptrend for CardioNet (NASDAQ:BEAT) on February 18th, 2016 at $11.21. In approximately 4 months, CardioNet has returned 42.64% as of today's recent price of $15.99.
BEAT: 15.89 (-0.13)
HealthEquity Q1 Earnings Top, Revenues Rise Y/Y; View Up
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 7:35AM CDT
Shares of HealthEquity Inc (HQY) increased almost 4% in after-hours following impressive first-quarter fiscal 2017 results.
AIRM: 36.93 (+0.90), HQY: 29.18 (+0.52), BEAT: 15.89 (-0.13), AHS: 40.31 (+0.83)
The Zacks Analyst Blog Highlights: Entercom Communications, BioTelemetry, First Majestic Silver, BG Staffing and Orrstown Financial Services
Zacks Equity Research - Zacks Investment Research - Tue May 31, 8:30AM CDT
The Zacks Analyst Blog Highlights: Entercom Communications, BioTelemetry, First Majestic Silver, BG Staffing and Orrstown Financial Services
ETM: 13.85 (+0.25), AG: 12.40 (-0.06), BEAT: 15.89 (-0.13), BGSF: 16.14 (+0.42), ORRF: 18.28 (+0.46)
Shares of BEAT Up 52.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue May 31, 12:15AM CDT
SmarTrend identified an Uptrend for CardioNet (NASDAQ:BEAT) on February 18th, 2016 at $11.21. In approximately 3 months, CardioNet has returned 52.19% as of today's recent price of $17.06.
BEAT: 15.89 (-0.13)
5 Breakout Stocks Under $20
Zacks Equity Research - Zacks Investment Research - Fri May 27, 11:15AM CDT
The breakout strategy is probably the most commonly used one by active investors.
ETM: 13.85 (+0.25), AG: 12.40 (-0.06), BEAT: 15.89 (-0.13), BGSF: 16.14 (+0.42), ORRF: 18.28 (+0.46)
Medical Service Stocks Should be on your Buying Radar
Zacks Premium Research - Zacks Investment Research - Wed May 25, 3:47PM CDT
Investing in this industry now could pay off for you over the short term.
HQY: 29.18 (+0.52), BEAT: 15.89 (-0.13), AHS: 40.31 (+0.83)
Uptrend Call Working As CardioNet Stock Rises 36.5% (BEAT)
Comtex SmarTrend(R) - Mon May 23, 12:56PM CDT
SmarTrend identified an Uptrend for CardioNet (NASDAQ:BEAT) on February 18th, 2016 at $11.21. In approximately 3 months, CardioNet has returned 36.53% as of today's recent price of $15.31.
BEAT: 15.89 (-0.13)
Waters Corp. Expands Xevo Line with Xevo TQ-XS Launch
Zacks Equity Research - Zacks Investment Research - Tue May 17, 8:44AM CDT
Waters Corporation (WAT) expanded its portfolio of Xevo mass spectrometers with the launch of Xevo TQ-XS mass spectrometer, which is arguably the most sensitive instrument of its kind in the market.
BEAT: 15.89 (-0.13), BRKR: 24.40 (+0.14), PKI: 54.23 (+0.99), WAT: 138.40 (+1.17)
BioTelemetry, Inc. Announces the Completion of Its Acquisition of VirtualScopics, Inc.
GlobeNewswire - Wed May 11, 8:25AM CDT
BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that it has completed its acquisition of VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions. The acquisition comes after the successful completion of the all cash tender offer for all outstanding common and preferred shares of VirtualScopics. The total purchase consideration was approximately $15.0 million, net of cash and debt acquired.
VSCP: 4.04 (+0.01), BEAT: 15.89 (-0.13)
BioTelemetry, Inc. Announces Results of Tender Offer for Shares of VirtualScopics, Inc.
GlobeNewswire - Tue May 10, 7:05AM CDT
BioTelemetry, Inc. (NASDAQ: BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that the tender offer of its wholly owned subsidiary, BioTelemetry Research Acquisition Corporation ("Offeror"
, to purchase all outstanding common and preferred shares of VirtualScopics, Inc. ("VirtualScopics"; (NASDAQ:VSCP) at an offer price of $4.05 per share for VirtualScopics' common stock, $336.30 per share for VirtualScopics' Series A and Series B Convertible Preferred Stock and $920.00 per share for VirtualScopics' Series C-1 Convertible Preferred Stock, expired as scheduled at 5:00 p.m., New York City time, on Monday, May 9, 2016, and was not extended. VSCP: 4.04 (+0.01), BEAT: 15.89 (-0.13)
BioTelemetry, Inc. Appoints Colin Hill to Its Board of Directors
GlobeNewswire - Fri May 06, 3:05PM CDT
BioTelemetry, Inc. (NASDAQ:BEAT) the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today the appointment of Colin Hill to its Board of Directors.
BEAT: 15.89 (-0.13)
Can The Uptrend Continue for BioTelemetry (BEAT)?
Zacks Equity Research - Zacks Investment Research - Fri May 06, 8:03AM CDT
Investors certainly have to be happy with BioTelemetry, Inc. (BEAT) and its short term performance.
BEAT: 15.89 (-0.13)
Why BioTelemetry (BEAT) Stock Might be a Great Pick
Zacks Equity Research - Zacks Investment Research - Wed May 04, 7:39AM CDT
BioTelemetry (BEAT) is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
BEAT: 15.89 (-0.13)
Looking for a Top Momentum Stock? 3 Reasons Why BioTelemetry (BEAT) is a Great Choice
Zacks Equity Research - Zacks Investment Research - Tue May 03, 8:16AM CDT
BioTelemetry is a great momentum stock and has been witnessing positive activity in the earnings estimate revision front as well
BEAT: 15.89 (-0.13)
Acadia Healthcare (ACHC) Beats on Q1 Earnings; Stock Up
Zacks Equity Research - Zacks Investment Research - Mon May 02, 9:44AM CDT
Shares of Acadia Healthcare Company Inc (ACHC) increased 1.6% to close at $63.19 on Apr 29, after the company reiterated its full-year 2016 guidance.
ACHC: 62.44 (+1.65), BAX: 45.96 (+1.02), BEAT: 15.89 (-0.13), EW: 99.08 (+1.04)
The Zacks Analyst Blog Highlights: Daqo New Energy, BioTelemetry, Ebix, Primo Water and Nanometrics
Zacks Equity Research - Zacks Investment Research - Mon May 02, 8:30AM CDT
The Zacks Analyst Blog Highlights: Daqo New Energy, BioTelemetry, Ebix, Primo Water and Nanometrics
PRMW: 10.89 (+0.16), DQ: 21.10 (+0.95), BEAT: 15.89 (-0.13), EBIX: 48.61 (+0.90), NANO: 20.62 (+0.26)
Universal Health (UHS) Tops Q1 Earnings on Strong Sales
Zacks Equity Research - Zacks Investment Research - Mon May 02, 5:53AM CDT
Universal Health Services Inc. (UHS) reported first-quarter 2016 adjusted earnings of $1.98 per share, which beat the Zacks Consensus Estimate by 12 cents.
BAX: 45.96 (+1.02), UHS: 138.28 (+3.44), BEAT: 15.89 (-0.13), EW: 99.08 (+1.04)
